Pain, Suffering, Over-Prescribing and Addiction What Have We Done, What Can We Do?

Size: px
Start display at page:

Download "Pain, Suffering, Over-Prescribing and Addiction What Have We Done, What Can We Do?"

Transcription

1 Pain, Suffering, Over-Prescribing and Addiction What Have We Done, What Can We Do? January 12, 2016 Trip Gardner, MD Chief Psychiatric Officer PCHC Noah Nesin, MD VP for Medical Affairs PCHC

2 How Did We End Up Here?

3 Weird Science

4 Weird Science No ceiling dose for opioids for chronic pain Essentially no risk of addiction Goal of extinguishing pain Pseudoaddiction

5 Real Science AHRQ September 30, 2014: Evidence of long-term opioid therapy for chronic pain is very limited, but suggests an increased risk of serious harms that appears to be dose-dependent.

6 Where Are We? 1991: 76 million opioid Rxs 2011: 219 million opioid Rxs Up to 70% of people with chronic pain are receiving improper treatment (according to NIH).

7 The Harm

8 The Harm Risk of addiction is 30 to 40% Drug overdose deaths increased 34% between 2011 and Mainers died of drug overdose in % of those were prescription drugs overdose EMS responses in pharmacy robberies in 2008, 136 since % of crime in Maine related to drug abuse

9 The Harm 961 babies born with NAS in Maine in % of babies born in Penobscot County are drug affected. 12% of Maine high school students report nonmedical use of prescription drugs in lifetime, 6% in last month. Maine leads the nation in the rate of prescriptions for long acting opioids (21.8 Rx/100 people vs. national average of 10.3) 265% increase in deaths from prescription opioid overdose in men since 1999, 400% in women

10 100 Morphine Equivalents What is High Dose?

11 We Have Not Yet Turned The Corner In Maine we prescribe opioids at a rate of 60.4 pills per capita. In Penobscot County we prescribe opioids at a rate of 63.2 pills per capita.

12 What Can We Do? 1. Stop over-prescribing 2. Learn how to treat chronic pain 3. Screen for Substance Use Disorder 4. Be willing to diagnose Substance Use Disorder 5. Be willing to refer for proper treatment 6. Apply proven treatments in our practices, with proper support

13 Challenges Barriers Time $$ Lack of expertise Lack of systems Lack of interest Stigma/Bias Barrier Busters Grants Time Support o ECHO o E-consults o Collaborative Identify champions Ethical appeal Support of skilled MH workers

14 HOPE Maine Chronic Pain Collaborative Addiction Task Force Community Health Leadership Board HRSA support for FQHCs Community Groups NIDA NE Clinical Trial Network CDC Guidelines, AHRQ, Johns Hopkins guidelines Project ECHO Buprenorphine PainNet Pain e consults Public Discourse Naloxone MEHAF Maine Quality Counts Maine PMP Maine Independent Clinical Information Service Lunder Dineen Health Education Foundation

15

16 What is Addiction? Trip Gardner, MD Chief Psychiatric Officer Penobscot Community Health Care

17 Addiction is American Society of Addiction Medicine April 2011 Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry. Dysfunction in these circuits leads to characteristic biological, psychological, social and spiritual manifestations. This is reflected in an individual pathologically pursuing reward and /or relief by substance use and other behaviors National Institute on Alcohol Abuse and Alcoholism Director Mark Willenbring, MD Wanting the wrong thing very badly National Institute on Drug Abuse Director Nora Volkow, MD The brains of addicted people have been modified by the drug in such a way that absence of the drug makes a signal to their brain that is equivalent to the signal of when you are starving. It is as if the individual was in a state of deprivation, where taking the drug is indispensable for survival. It's as powerful as that.

18 Addiction is an illness 1784 to 1900 Benjamin Rush 1784 Inquiry into the Effects of Ardent Spirits on the Human Mind and Body Physicians thought chronic inebriety was diseased state characterized by: Biologic predisposition Drug toxicity Pharmacologic tolerance Disease progression Morbid appetite (craving) Loss of volitional control of alcohol/drug intake Pathophysiologic consequences It is curable in the same sense that other diseases are Concern grew among physicians about addiction to drugs other than alcohol, Widespread distribution of opiate- and cocaine-based medicines by a rapidly growing patent drug industry

19 Addiction is not an illness ( ) Biologic views of addiction fell out of favor and were replaced by: Character problem Moral problem Criminal problem State and national prohibition laws were passed as the solution Addiction treatment institutions closed in great numbers. Harrison Antinarcotic Act if physician to maintains an addict on opioid: Not in good faith medical practice Indictable offense.

20 Addiction is an illness (1935 on) Kinda?Sorta? It is an illness state addiction hospitals Methadone maintenance Office based opioid treatment with buprenorphine Medication Assisted Treatment of Alcohol Use Disorder SBIRT - Screening Brief Intervention Referral to Treatment in Primary Care Evidenced based psychotherapies are available It is not an illness 65% of those in long term criminal justice have addiction they get little treatment Insurance funding cut > any other illness Evidenced based practice for pain pill prescriptions not applied toxic risks of opioid pain pills not seriously considered Many physicians still don t fully recognize as illness Do not diagnose Document these symptoms in the social history not the medical history

21 Myths about Addiction 1. People with addiction are bad, crazy, or stupid. 2. Addiction is a willpower problem. 3. People with addiction should be punished, not treated, for using drugs. 4. People with addiction cannot be treated with medications. 5. Addiction does not get better until you hit rock bottom.

22 Epidemiology

23 2014 Users - Nationally

24

25 2014 Disordered - Nationally million people with diabetes

26 Maine use higher but diagnoses lower People are using more Alcohol use 59.07% US 52.42% Illicit drug use 13.50% US 9.77% = 29.11% 6 TH HIGHEST IN COUNTRY We are not diagnosing Alcohol Use Disorder 5.71% US 6.5% Drug Use Disorder 2.62% US 2.64% Alcohol and/or Drug Use Disorder 7.67% US 8.16%

27 Benzo Heroin Fentanyl

28 Risk Factors for Substance Use Disorders Men > Women Physical or sexual abuse when young Younger age of 1 st use Caucasians > Hispanics and African Americans Unemployed Not in stable marriage or cohabiting situation Not graduating college Co-occurring other psychiatric brain disorders

29 Etiology

30 Genetic -50 % of the risk Normal At Risk

31

32 Environment Factors Stress can turn on genes Adverse childhood events Physical or sexual abuse Modeling Lack of healthy coping skill development Peers who use have more influence in adolescence Drug availability

33 Developmental Factors Adolescents are most at risk The brain undergoing development Making it easier to develop a long term altered circuit Impulse control centers not fully matured leading to poorer judgement Have less developed healthy coping skills More susceptible to peer pressure

34 Mechanism

35 How?

36 Increase Dopamine > Natural Rewards This translates into a highly rewarding message in our thoughts. The high dopamine environment causes enhanced learning of the conditions associated with the reward so that these conditions serve as triggers for the drive leading to the reward seeking behavior as if it were a basic need for survival.

37 Why do people with substance use disorders keep using drugs? Long-term drug and alcohol abuse changes in the brain including: Exaggerated drive in response to triggers Inability to exert control over the impulse to use Diminished recognition of adverse consequences Changes persist after a person stops using drugs Psychological stress from work, family problems, psychiatric illness, pain, social or environmental past cues can trigger intense cravings without the individual even being consciously aware of the triggering event

38 How?

39

40 Reward circuit is hyperactive - overactive go Control circuit is impaired damaged stop Disconnection of communication in the circuits

41 Orbitofrontal Cortex

42 The brain lights up at the thought

43 The Disease Deepens As Time Goes On

44 Tolerance dom-logo

45 Same as other chronic illnesses

46 Symptoms and signs of the Illness

47 Diagnosis Criteria DSM 5 Substance Use Disorder Checklist Worksheet for DSM-5 criteria for diagnosis of Substance Use Disorder Note: In diagnosis substitute specific substance for example if the substance is cannabis the diagnosis would be Cannabis Use Disorder Diagnostic Criteria (Substance Use Disorder requires at least 2 criteria be met within a 12 month period) 1. The substance is often taken in larger amounts or over a longer period of time than intended. 2. There is a persistent desire or unsuccessful efforts to cut down or control the substance use. 3. A great deal of time is spent in activities necessary to obtain the substance, use the substance, or recover from its effects. 4. Craving, or a strong desire to use the substance. 5. Recurrent substance use resulting in failure to fulfill major role obligations at work, school or home. 6. Continued substance use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance. 7. Important social, occupational or recreational activities are given up or reduced because of the substance use. 8. Recurrent substance use in situations in which it is physically hazardous 9. Continued use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance. 10. *Tolerance, as defined by either of the following: (a) a need for markedly increased amounts of the substance to achieve intoxication or desired effect (b) markedly diminished effect with continued use of the same amount of the substance 11. *Withdrawal, as manifested by either of the following: (a) the characteristic substance withdrawal syndrome (b) the same (or a closely related) substance are taken to relieve or avoid withdrawal symptoms Meets criteria? Yes No Notes/Supporting information *This criterion is not considered to be met for those individuals taking substances solely under appropriate medical supervision. Severity: Mild: 2-3 symptoms, Moderate: 4-5 symptoms. Severe: 6 or more symptoms Specifiers 1. In early remission no criteria met for 3-12m 2. In sustained remission no criteria for 12m or >

48 Treatment

49 Continuum of care same as any other illness Brief education and intervention for those with high risk signs Brief outpatient therapy for those with risky use ( pre diabetes ) Outpatient counseling Medication assisted treatment and outpatient counseling Intensive outpatient Partial hospitalization Hospitalization Hospitalization with intensive long term care

50 Essentials of Effective Treatment 1. Addiction is a complex but treatable disease of brain function and behavior. 2. No single treatment is appropriate for everyone. 3. Treatment needs to be readily available. 4. Effective treatment attends to multiple needs of the individual. 5. Remaining in treatment for an adequate period of time is critical. 6. Many drug-addicted individuals also have other mental disorders 7. Medically assisted detoxification is only the first stage of addiction treatment. 8. Treatment does not need to be voluntary to be effective. 9. Drug use during treatment must be monitored continuously 10. Like any disease progress in treatment is individualized.

51 Treatment Gaining the ability to stop abusing drugs is just one part of a long and complex recovery process. When people enter treatment for a substance use disorder, addiction has often taken over their lives. The compulsion to get drugs, take drugs, and experience the effects of drugs has dominated their every waking moment, and abusing drugs has taken the place of all the things they used to enjoy doing. It has disrupted how they function in their family lives, at work, and in the community, and has made them more likely to suffer from other serious illnesses. Because addiction can affect so many aspects of a person s life, treatment must address the needs of the whole person to be successful. This is why the best programs incorporate a variety of rehabilitative services into their comprehensive treatment regimens. Treatment counselors may select from a menu of services for meeting the specific medical, psychological, social, vocational, and legal needs of their patients to foster their recovery from addiction. Medications Used To Treat Drug Addiction Detoxification Medications Tobacco Use Disorder Nicotine replacement therapies, Bupropion, Varenicline Opioid Use Disorder Methadone, Buprenorphine, Naltrexone Alcohol Use Disorder Naltrexone, Disulfiram, Acamprosate Evidenced Based Psychological Therapies Cognitive Behavioral Therapy Seeks to help patients recognize, avoid, and cope with the situations in which they are most likely to abuse drugs. Contingency Management Uses positive reinforcement such as providing rewards or privileges for remaining drug free, for attending and participating in counseling sessions, or for taking treatment medications as prescribed. Motivational Enhancement Therapy Uses strategies to evoke rapid and internally motivated behavior change to stop drug use and facilitate treatment entry. Family Therapy (especially for youth) approaches a person s drug problems in the context of family interactions and dynamics that may contribute to drug use and other risky behaviors.

52 Methadone and buprenorphine are not heroin/opioid substitutes. Prescribed under monitored, controlled conditions Heroin causes immediate "rush," that wears off quickly and ends in a "crash. Cycle of euphoria, crash, and craving is a hallmark of addiction Methadone/buprenorphine - gradual onsets of action producing stable levels Patients maintained on these medications no rush, no desire to use Dampens or suppresses the euphoric effects of other opioids Help to stabilize individual functioning, allowing treatment of their problems Allows patients to hold jobs, avoid street crime and violence, and reduce their exposure to HIV/Hepatitis Allows patients to engage more readily in counseling and other behavioral interventions essential to recovery.

53

54 Aftercare As is the case with all chronic diseases the condition must be monitored and managed over time to: Decrease the frequency and intensity of relapses Sustain periods of remission Optimize the person s level of functioning during periods of remission Frequently done in groups Continuing care for chronic disease same as you would for diabetes

55 Outcomes

56 Recovery Best achieved through a combination of: Self management Social support Professional care Right medicine with right counseling gives leg up in recovery The chronic nature of the disease means that relapsing to drug abuse is possible, with symptom recurrence rates similar to those for diabetes, hypertension, and asthma

57 Outcomes 33% remission % substantial improvement 20-30% little to no improvement

58 Outcomes as good as other chronic diseases

59 ADDICTION RECOVERY IS ASSOCIATED WITH DRAMATIC IMPROVEMENTS IN ALL LIFE AREAS Criminal justice system involvement decreases 10 fold Steady employment increases by over 50% Emergency departments decreases 10 fold Paying bills on time, paying back personal debt doubles Planning for the future increases 3-fold Involvement in domestic violence decreases Volunteering in the community increases 3-fold Voting increases to > 80% Untreated mental health problems decrease 4- fold Further their education or training by 2 fold Report paying taxes, having good credit Start and own business % after 10y Participation in family activities increases to 95%. Laudet A; Life in Recovery Report on Survey Findings, FACES ANDVOICES OF RECOVERY.org, April 2013

60 Same determinants of health for all illnesses

61 Outcome misperception Studies of treatment done on those with the most severe illnesses Mild to Moderate AUD gets better but we don t usually measure unlike diabetes, hypertension Most people do recover but it is a social secret because of stigma We should measure outcome like other medical disorders by reduction of disease related adverse outcomes

Opioid Use Issues: All the Players

Opioid Use Issues: All the Players Opioid Use Issues: All the Players Objectives After review, the participant will be able to: 1) Identify criteria for opioid use disorders Andrew J. McLean, MD, MPH Medical Director, ND Department of Human

More information

Opiate Use Disorder and Opiate Overdose

Opiate Use Disorder and Opiate Overdose Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance

More information

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING

More information

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:

More information

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW DSM-5 AND ASAM CRITERIA Presented by Jaime Goffin, LCSW MODULE 1: GOALS & OBJECTIVES What is your experience with using ASAM and DSM 5 criteria? What are your learning expectations for today? GOAL FOR

More information

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Medication-Assisted Treatment. What Is It and Why Do We Use It? Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite

More information

HOUSE Calls. Addiction Medicine. Winter Published by the Alachua County Medical Society

HOUSE Calls. Addiction Medicine. Winter Published by the Alachua County Medical Society HOUSE Calls Published by the Alachua County Medical Society Winter 2017 Addiction Medicine Addiction as a Disease Gregory L. Jones, MD, FASAM, FAAF, UF Health Florida Recovery Center Scott A. Teitelbaum,

More information

Substance Use Disorders

Substance Use Disorders Substance Use Disorders Substance Use Disorder This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and

More information

Neurobiology of Drug Abuse and Addiction PSYC 450

Neurobiology of Drug Abuse and Addiction PSYC 450 Neurobiology of Drug Abuse and Addiction PSYC 450 Healthy Control Drug Abuser Illicit drug use, lifetime and past year, in Canada 50 Canabis only Any drug Any of 5 drugs (without canabis) (CADUMS 2012)

More information

Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC

Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC Opioid Use Disorders and Their Treatment Mark Edlund, MD, PhD RTI International Photo courtesy of The Herb Museum, Vancouver, BC Acknowledgements Funded by NIDA R01 DA022560-01 NIDA R01 DA034627 NIDA R01

More information

2/21/2018. What are Opioids?

2/21/2018. What are Opioids? Opioid Crisis: South Carolina Responds Carolyn Bogdon, MSN, FNP-BC Coordinator for Emergency Department Medication Assisted Treatment Program Medical University of South Carolina Opioid Crisis: A Mounting

More information

Addiction. Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine

Addiction. Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine Addiction Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine Twitter: @rcwallermd Objectives Understand the Concept of Addiction Survival FOOD WATER DOPAMINE

More information

Appendix F Federation of State Medical Boards

Appendix F Federation of State Medical Boards Appendix F Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office SECTION I: PREAMBLE The (name of board) recognizes that the prevalence of addiction

More information

Chapter 7. Screening and Assessment

Chapter 7. Screening and Assessment Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions

More information

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization

More information

Treatment Team Approaches in Substance Abuse Treatment

Treatment Team Approaches in Substance Abuse Treatment Treatment Team Approaches in Substance Abuse Treatment PLANT A SEED AND WATCH IT GROW 2 Substance use disorders span a wide variety of problems arising from substance use, and cover 11 different criteria:

More information

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.

More information

Opioids and Opioid Addiction: Practical Management Approaches

Opioids and Opioid Addiction: Practical Management Approaches Opioids and Opioid Addiction: Practical Management Approaches Yngvild Olsen, MD, MPH Medical Director Institutes for Behavior Resources Inc/REACH Health Services Conflict of Interest No financial or advisory

More information

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States

More information

Restoration of Parenting Ability Through Treatment for Substance Use Disorders

Restoration of Parenting Ability Through Treatment for Substance Use Disorders Restoration of Parenting Ability Through Treatment for Substance Use Disorders DEBRA M. BARNETT, MD Board Certified in General Psychiatry, Addiction Psychiatry, Geriatric Psychiatry, and Forensic Psychiatry

More information

Drug Addiction Is a Disease So What Do We Do about It?

Drug Addiction Is a Disease So What Do We Do about It? Lesson 5 Elaborate/ Evaluate Drug Addiction Is a Disease So What Do We Do about It? Photo courtesy of Gray Wolf Ranch Wilderness Recovery Lodge. Overview Students make predictions about the success rate

More information

Clinical Evaluation: Assessment Goals

Clinical Evaluation: Assessment Goals Clinical Evaluation: Assessment Goals 1. Define Assessment Process 2. Identify Assessment Instruments 3. Define DSM-5 criteria for Substance Abuse and Dependence, specifiers and multi-axial assessment

More information

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Medication Assisted Treatment Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Disclosures Employed by the Department of Veterans Affairs

More information

Council on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain

Council on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain Council on Chemical Abuse Annual Conference November 2, 2017 The Science of Addiction: Rewiring the Brain David Reyher, MSW, CAADC Behavioral Health Program Director Alvernia University Defining Addiction

More information

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS Ending Addiction Changes Everything RECOMMENDATIONS FOR HEALTH CARE PROVIDERS CRITICAL ADDICTION PREVENTION, TREATMENT AND MANAGEMENT SERVICES TO INCLUDE IN ROUTINE HEALTH CARE PRACTICE JULY 2013 In the

More information

Best Practice Workgroup Considerations. New Jersey Shared Values: Unified Child Welfare Practice Conference April 29, 2011

Best Practice Workgroup Considerations. New Jersey Shared Values: Unified Child Welfare Practice Conference April 29, 2011 New Jersey Shared Values: Unified Child Welfare Practice Conference April 29, 2011 Evidence-based and Innovative Treatment Models: Setting the Stage for our Discussions Best Practice Workgroup Considerations

More information

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over

More information

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) 1 Expanded to include Gambling Disorder Cannabis Withdrawal and Caffeine Withdrawal are new disorders Caffeine Withdrawal

More information

Brief History of Methadone Maintenance Treatment

Brief History of Methadone Maintenance Treatment METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what

More information

4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H.

4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H. MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H. MEDICAL DIRECTOR, UNITYPOINT HEALTH MERITER/ NEWSTART ADJUNCT PROFESSOR, UNIVERSITY OF WISCONSIN MADISON

More information

Hot Topics in Addiction Medicine. Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017

Hot Topics in Addiction Medicine. Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017 Hot Topics in Addiction Medicine Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017 Financial Disclosures Speaker Bureau Indivior Research Support Constellation Health Onward Hot Topics

More information

Understanding Addiction: Why Can t Those Affected Just Say No?

Understanding Addiction: Why Can t Those Affected Just Say No? Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions

More information

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?

More information

Substance Use Disorder Part One: The Basics of Recovery

Substance Use Disorder Part One: The Basics of Recovery Substance Use Disorder Part One: The Basics of Recovery Paula Heller Garland, MS, LCDC University of North Texas Department of Disability & Addiction Rehabilitation Workshop Overview How do you know that

More information

11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no Dean Drosnes, MD, FASAM Associate Medical Director Caron Treatment Centers ASAM Disclosure of Relevant Financial Relationships Date of Activity: Nov 3, 2016 Name Commercial Interests Relevant Financial

More information

Critiquing the Construction of Addiction: Dependence, Disorder and the DSM V

Critiquing the Construction of Addiction: Dependence, Disorder and the DSM V Critiquing the Construction of Addiction: Dependence, Disorder and the DSM V Helen Keane School of Sociology Australian National University Addiction A hybrid moral medical category defined by pathological

More information

SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION

SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION ANNABELLE SIMPSON, MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES

More information

Module 6: Substance Use

Module 6: Substance Use Module 6: Substance Use Part 1: Overview of Substance Abuse I am Martha Romney and I am presenting on substance abuse. This module focuses on the healthy people 2020 objective to reduce substance abuse

More information

New London CARES Coordinated Access, Resources, Engagement and Support

New London CARES Coordinated Access, Resources, Engagement and Support New London CARES Coordinated Access, Resources, Engagement and Support What are Opioids? Class of drugs that include Heroin Prescription pain relievers oxycodone (OxyContin), hydrocodone (Vicodin), codeine,

More information

Data Driven Strategies

Data Driven Strategies Data Driven Strategies Full Task Force Meeting September 16, 2014 Review the problems Snapshot of local data Task Force goals Risk factors Breakout groups Prevention Intervention Treatment Recovery Words

More information

590,000 deaths can be attributed to an addictive substance in some way

590,000 deaths can be attributed to an addictive substance in some way Mortality and morbidity attributable to use of addictive substances in the United States. The Association of American Physicians from 1999 60 million tobacco smokers in the U.S. 14 million dependent on

More information

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings BRIAN GARVEY, MD, MPH REBECCA CANTONE, MD OREGON HEALTH & SCIENCE UNIVERSITY SCAPPOOSE RURAL HEALTH CENTER Disclosures

More information

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT Goals of Discussion Recognize opioid use disorder (OUD) Discuss the pharmacology of medication assisted treatments (MAT)

More information

Medicated Assisted Treatment

Medicated Assisted Treatment Medicated Assisted Treatment Enhancing the Potential for Recovery Part I Diana Padilla Program Manager NeC-ATTC 2 Diana Padilla, RCR, CASAC-T padilla@ndri.org Diana Padilla is a program manager at NDRI-USA,

More information

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives

More information

Commi ee Lecture: Neurocogni ve Disorders TBI : Trauma c Brain Disorders. William L. Bograkos, MA, DO, FACOEP

Commi ee Lecture: Neurocogni ve Disorders TBI : Trauma c Brain Disorders. William L. Bograkos, MA, DO, FACOEP Commi ee Lecture: Neurocogni ve Disorders TBI : Trauma c Brain Disorders Toxic Brain Disorders William L. Bograkos, MA, DO, FACOEP TBI: Traumatic Brain Injury / Toxic Brain Injury (Trauma and Substance

More information

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016 What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)

More information

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower.

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower. The Opiate Crisis Presented by Dr. Anahi Ortiz Franklin County Coroner April 9, 2018 Words are important. If you want to care for something, you call it a flower. If you want to kill something, you call

More information

Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no Dr. Joseph Garbely Medical Director VP of Medical Services Caron Treatment Centers 1 ASAM Disclosure of Relevant Financial Relationships No Relevant Financial Relationships with Any Commercial Interests

More information

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response. OPIOIDS IN AMERICA A complex crisis. A comprehensive response. Prescription opioids play a critical role in helping millions of people effectively manage chronic pain. But for some, opioid use has become

More information

Module Three Screening and Assessment V

Module Three Screening and Assessment V Module Three Screening and Assessment V1.7.13.141031 Introduction to Modules Three and Four Modules Three and Four cover the key components of SBIRT screening, assessment and brief intervention. The screening,

More information

Opioid Epidemic Update

Opioid Epidemic Update Opioid Epidemic Update - 2018 Talal Khan MD Addiction Psychiatrist Pine Rest What are Opioids? Opiates are alkaloid compounds naturally found in the opium Poppy plant. Papaver somniferum The psychoactive

More information

Treating Opioid Addiction

Treating Opioid Addiction Treating Opioid Addiction Some people who start taking opioid pain medications eventually have serious problems with them and become addicted. Every day, 68 people die in the US from opioid overdose. More

More information

Noel Schenk MD. Davis Behavioral Health

Noel Schenk MD. Davis Behavioral Health Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by

More information

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Beyond Birth: A Comprehensive Recovery Center serving parenting women Beyond Birth: A Comprehensive Recovery Center serving parenting women Session Objectives Highlight Plan of Safe Care Introduce the Beyond Birth Comprehensive Recovery Center Describe Levels of Care The

More information

MAT in the Corrections Setting

MAT in the Corrections Setting MEDICATION ASSISTED TREATMENT AND CORRECTIONS Frank Filippelli, DO, PhD September 2017 MAT in the Corrections Setting Who Does This Affect? What is MAT and What is the Evidence of Efficacy? Emphasis on

More information

Navigating the. Addiction. A Four-Letter Word!!! What is Addiction? Definition of Addiction: Definition of Addiction: (cont)

Navigating the. Addiction. A Four-Letter Word!!! What is Addiction? Definition of Addiction: Definition of Addiction: (cont) Navigating the Addiction of What is Addiction? Addiction is a slow, gradual, insidious, elusive becoming! Caroline Knapp Presented by: Thomas W. O Reilly, MS, PCC-S Lakeshore Educational & Counseling Services

More information

Anyone Can Become Addicted. Anyone.

Anyone Can Become Addicted. Anyone. Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.

More information

WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS

WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS René Lento, PhD Lauren Brenner, PhD September 25, 2018 DISCLOSURES None HOME BASE PROGRAM 3 LEARNING OBJECTIVES

More information

BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH

BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH THERAPEUTIC INTERVENTION AND RESOURCE MANAGEMENT: SUBSTANCE RELATED DISORDERS: CO-DEPENDENCY AND THE IMPAIRED NURSE LECTURE OBJECTIVES:

More information

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation

More information

Substance Use Disorders in Primary Care

Substance Use Disorders in Primary Care Substance Use Disorders in Primary Care Jin Hee Yoon-Hudman, MD Assistant Vice President, Medical Director, Behavioral Health Healthfirst Fall Symposium Prevention as a Priority in Value-Based Healthcare,

More information

Addiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017

Addiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017 Addiction Overview Causes Consequences Treatments Methadone/Buprenorphine 101 April 1, 2017 Diane A. Rothon MD Why? would you listen to this presentation Review the definition and neurobiology of addiction

More information

The Importance of Psychological Treatment and Behavioral Support

The Importance of Psychological Treatment and Behavioral Support The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding

More information

Building capacity for a CHC response to Ontario's Opioid Crisis

Building capacity for a CHC response to Ontario's Opioid Crisis Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC

More information

Note: The trainings below represent a foundational list, and may be adapted based on audience and need.

Note: The trainings below represent a foundational list, and may be adapted based on audience and need. MOTIVATIONAL INTERVIEWING Introduction to Motivational Interviewing (offered in English and Spanish) 2-day Course (12-14 credit hours) This course is designed to introduce clinicians and staff members

More information

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine [Patient-focused, evidence-based addiction treatment] Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine BrightView Health All Rights Reserved www.brightviewhealth.com

More information

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and

More information

V. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS

V. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS V. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS R esearch evidence supports the effectiveness of various substance abuse treatment approaches for adolescents. Examples of specific

More information

MASS COMMUNICATIONS The traditional realm of mass communications includes television,

MASS COMMUNICATIONS The traditional realm of mass communications includes television, Appendix C: Perspectives on Defining Substance c Abuse F our broad arenas that encounter substance abuse-related issues include, mass communications, criminal justice, medicine, and public health. These

More information

THE STATE OF MEDICINE IN ADDICTION RECOVERY

THE STATE OF MEDICINE IN ADDICTION RECOVERY OVERVIEW: Review addiction stats and trends Define addiction Explain neurobiology of addiction Review treatments of addiction Addiction Definition: A Primary, chronic, relapsing disease of brain reward,

More information

OUTPATIENT TREATMENT WESTPORT, CONNECTICUT

OUTPATIENT TREATMENT WESTPORT, CONNECTICUT OUTPATIENT TREATMENT WESTPORT, CONNECTICUT ABOUT CLEARPOINT At Clearpoint, we focus on healing the whole person: mind, body, and spirit. Our comprehensive care methods set clients up for long-term success

More information

The Role of Urgent Care in responding to the opioid Crisis

The Role of Urgent Care in responding to the opioid Crisis The Role of Urgent Care in responding to the opioid Crisis Robert S Crausman MD MMS Partner, Ocean State Urgent Care and Primary Care Centers Clinical Professor of Medicine, Brown Rob@OSUC.net Opioid Crisis

More information

Neuroscience of Addiction

Neuroscience of Addiction Neuroscience of Addiction Carlton Erickson, Ph.D. Associate Dean for Research and Graduate Studies Distinguished Professor of Pharmacology Director, Addiction Science Research and Education Center College

More information

The Role of the PDMP: Foundational Knowledge and Best Practices

The Role of the PDMP: Foundational Knowledge and Best Practices The Role of the PDMP: Foundational Knowledge and Best Practices Brent I. Fox, PharmD, PhD Health Outcomes Research and Policy Harrison School of Pharmacy Auburn University DISCLOSURE I, Brent Fox, have

More information

Medication for Addiction Treatment (MAT)

Medication for Addiction Treatment (MAT) SBIRT Training Screening, Brief Intervention & Referral to Treatment Medication for Addiction Treatment (MAT) The Faith & Spirituality Integrated SBIRT Network Navigating the Training Welcome! These health

More information

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut Focusing on Highly Vulnerable Populations Track Pragmatic and Creative Responses to the Opioid Crisis in Connecticut A special thanks to our presenting sponsor: Presenters: Shawn Lang Deputy Director AIDS

More information

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:

More information

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health

More information

III. FREQUENTLY ASKED QUESTIONS

III. FREQUENTLY ASKED QUESTIONS III. FREQUENTLY ASKED QUESTIONS 1. Why do adolescents take drugs? Adolescents experiment with drugs or continue taking them for several reasons, including: To fit in: Many teens use drugs because others

More information

Pain and Addiction. Edward Jouney, DO Department of Psychiatry

Pain and Addiction. Edward Jouney, DO Department of Psychiatry Pain and Addiction Edward Jouney, DO Department of Psychiatry Case 43 year-old female with a history chronic lower back pain presents to your clinic ongoing care. She has experienced pain difficulties

More information

Effective Treatment: Doing the Right Thing, In the Right Way. Terrence D Walton, MSW, ICADC

Effective Treatment: Doing the Right Thing, In the Right Way. Terrence D Walton, MSW, ICADC Effective Treatment: Doing the Right Thing, In the Right Way Terrence D Walton, MSW, ICADC Monitor Manage Impact 1. Understand the Treatment Field, including Evidenced Based Practices 2. Understand Your

More information

City of Lawrence 2010 Alcohol Tax Funds Request for Proposals Calendar Year 2010 ( January December) Cover Page

City of Lawrence 2010 Alcohol Tax Funds Request for Proposals Calendar Year 2010 ( January December) Cover Page City of Lawrence 2010 Alcohol Tax Funds Request for Proposals Calendar Year 2010 ( January December) Cover Page Agency Name: Program Name: Contact Person: DCCCA, Inc First Step at Lake View Lisa Carter,

More information

Overview of Opioid Use Disorder

Overview of Opioid Use Disorder Overview of Opioid Use Disorder Doug Burgess, MD Medical Director of Outpatient Services, Truman Medical Centers Assistant Professor of Psychiatry, University of Missouri- Kansas City Objectives History

More information

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement TANNER NISSLY DO, BOB LEVY MD FASAM, MICHELE MANDRICH MSW, CMPE AS YOU ENTER, PLEASE SET UP TO PARTICIPATE IN OUR POLL EVERYWHERE

More information

Substance Abuse Level of Care Criteria

Substance Abuse Level of Care Criteria Substance Abuse Level of Care Criteria Table of Contents SUBSTANCE ABUSE OUTPATIENT: Adolescent... 3 SUBSTANCE ABUSE PREVENTION: Adult... 7 OPIOID MAINTENANCE THERAPY: Adult... 8 SUBSTANCE ABUSE INTERVENTION:

More information

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007 Alberta Alcohol and Drug Abuse Commission POSITION ON ADDICTION AND MENTAL HEALTH POSITION The Alberta Alcohol and Drug Abuse Commission (AADAC) recognizes that among clients with addiction problems, there

More information

Module II Opioids 101 Opiate Opioid

Module II Opioids 101 Opiate Opioid BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module II Opioids 101 Module II Goals of the Module This module reviews the following:! Opioid addiction and the brain!

More information

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe

More information

54 W Broadway Street, Suite 2 Shelbyville, Indiana January/February 2018

54 W Broadway Street, Suite 2 Shelbyville, Indiana January/February 2018 54 W Broadway Street, Suite 2 Shelbyville, Indiana 46176 317-398-3135 www.shelbycountydrugfree.com January/February 2018 Protecting Children from Prescription Stimulant Abuse Stimulant medications including

More information

Understanding Addiction Implications for Practice

Understanding Addiction Implications for Practice Understanding Addiction Implications for Brad Lander PhD, LICDC-CS Clinical Director / Psychologist Talbot Hall - Addiction Medicine at The Ohio State University Wexner Medical Center 3 Reward System The

More information

1 STUDYING THE STUDY DRUG: ADDERALL. iaddiction.com

1 STUDYING THE STUDY DRUG: ADDERALL. iaddiction.com 1 STUDYING THE STUDY DRUG: ADDERALL Societal Impact of the Drug A stimulant often prescribed for attention deficit hyperactivity disorder (ADHD) and narcolepsy, Adderall has become a drug of choice for

More information

NIDA Principles of Treatment. NIDA Principles of Treatment. Peter Banys, M.D., M.Sc. No single treatment is appropriate for all individuals.

NIDA Principles of Treatment. NIDA Principles of Treatment. Peter Banys, M.D., M.Sc. No single treatment is appropriate for all individuals. NIDA Principles of Treatment Peter Banys, M.D., M.Sc. CSAM Addiction Medicine Review Course San Francisco October 5 th, 2006 NIDA Principles of Treatment 1. Treatment Matching 2. Availability 3. Domains

More information

The Opioid Epidemic and Youth Prescription Drug Abuse. Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth

The Opioid Epidemic and Youth Prescription Drug Abuse. Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth The Opioid Epidemic and Youth Prescription Drug Abuse Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth Disclosures: I have no relevant financial relationships with the manufacturer(s)

More information

Update on Medications for Tobacco Cessation

Update on Medications for Tobacco Cessation Update on Medications for Tobacco Cessation Marc Fishman MD Johns Hopkins University Dept of Psychiatry Maryland Treatment Centers Baltimore MD MDQuit Best Practices Conference Jan 2013 Nicotine Addiction

More information

The science of the mind: investigating mental health Treating addiction

The science of the mind: investigating mental health Treating addiction The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with

More information

Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations

Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations Kamala Greene Genece, Ph.D. VP, Clinical Director Phoenix Houses of New York Benjamin R. Nordstrom, M.D., Ph.D. President

More information

Opioid Addiction Statistics

Opioid Addiction Statistics May 2017 Opioid Addiction Statistics Definitions Heroin Epidemic - As pill mills close, prescribing is becoming tighter, demand among younger users rise, and dealer s profits rise, addicts are turning

More information

Substance Use and Mental Health Disorders: Challenges for Primary Care

Substance Use and Mental Health Disorders: Challenges for Primary Care Substance Use and Mental Health Disorders: Challenges for Primary Care Ted Parran MD FACP Carter and Isabel Wang Professor of Medical Education CWRU School of Medicine tvp@cwru.edu Euphoria Producing Drugs

More information